Nanovelos
NANOVELOS - Drug Release Control Technology offered by NanoVelos demonstrates its power by transforming generics to super-generics via an innovative delivery system: they exhibit dramatically improved tumor targeting, thereby enhancing therapy efficacy while minimizing adverse effects on healthy tissues. Nanovelos offers also an adaptation of its proprietary drug delivery system for your anticancer drug. We can conjugate highly potent drugs that struggle to enter preclinical or clinical trials due to the intolerable toxicity or fast clearance.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
2
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Nanovelos
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
- TC
Tomasz Ciach
Founder, Research Coordinator · Other
EmailPhone - WK
Wioletta Kośnik
Project Manager Preclinical Research · Other
EmailPhone
Showing 2 of 2 verified contacts
Top roles at Nanovelos
2 distinct titles indexed · top 2 shown.
- 1founder, research coordinator
- 1project manager preclinical research
Sign up to unlock all 2 contacts at Nanovelos
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Nanovelos
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.